MetaCap

Bionano Genomics (BNGO) vs Circle8 Group (CIRC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bionano Genomics (BNGO) has outperformed Circle8 Group (CIRC) over the past year, losing 49.2% versus a loss of 94.4%. Over five years, CIRC leads with a -99.9% price change compared with -100.0% for BNGO. Circle8 Group is the larger company by market cap ($16.0 million vs $11.5 million), about 1.4 times the size.

Circle8 Group converts more of its revenue into profit, with a net margin of -13.6% versus -92.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BNGO-49.25%CIRC-94.44%
+93%-5%-103%
Nov 21, 20251 yearNov 20, 2026
BNGO-99.97%CIRC-99.88%
+5%-50%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BNGO versus CIRC key metrics
MetricBNGOCIRC
Share price$0.8222$0.1361
Market cap$11.50M$15.99M
1-day change-7.11%-12.25%
YTD return-46.26%-89.77%
1-year return-49.25%-94.44%
5-year return-99.97%-99.88%
EPS (TTM)$-1.96$-2.14
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$28.51M$435.88M
Revenue growth (YoY)-7.37%-1.52%
Net income (latest FY)$-26.39M$-59.43M
Gross margin46.25%10.55%
Operating margin-116.95%-11.52%
Net margin-92.59%-13.63%
52-week high$2.23$4.56
52-week low$0.81$0.136
Distance from 52-week high-63.13%-97.02%
Analyst consensusnone—
Avg. price target upside+508.12%—
Average volume979.44K1.13M
Shares outstanding13.99M117.49M
Employees95300
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BNGO has outperformed CIRC by 45.2 percentage points over the past year.
  • Circle8 Group is more profitable, keeping -13.6 cents of every revenue dollar as net income versus -92.6 cents for Bionano Genomics.
  • Circle8 Group grew revenue faster in its latest fiscal year (-1.52% vs -7.37%).

About Bionano Genomics

BNGO stock →

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees

About Circle8 Group

CIRC stock →

Circle8 Group, Inc. provides talent management services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 300 employees

BNGO vs CIRC FAQ

Which is bigger, Bionano Genomics or Circle8 Group?

Circle8 Group (CIRC) is larger, with a market capitalization of $15.99M compared with $11.50M for Bionano Genomics (BNGO).

Which stock has performed better over the past year, BNGO or CIRC?

BNGO returned -49.25% over the past 12 months, compared with -94.44% for CIRC (price return, excluding dividends). Past performance does not predict future results.

Are Bionano Genomics and Circle8 Group in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons